AHA: Daily Marijuana Use Linked to Incident Heart Failure
By Elana Gotkine HealthDay Reporter
MONDAY, Nov. 13, 2023 -- Daily marijuana use is associated with incident heart failure, and cannabis use disorder (CUD) is associated with increased odds of major adverse cardiac and cerebrovascular events (MACCE), according to two studies presented at the American Heart Association Scientific Sessions 2023, held from Nov. 11 to 13 in Philadelphia.
Yakubu Bene-Alhasan, M.D., M.P.H., from Medstar Health in Baltimore, and colleagues used data from the National Institutes of Health "All of Us" Research Program to examine the association between the frequency of marijuana use and new-onset heart failure. The researchers found there were 2,958 events within a median follow-up of 45 months from a final population of 156,999 patients. Daily marijuana use was associated with an increased risk for incident heart failure compared with never use (adjusted hazard ratio, 1.34; 95 percent confidence interval, 1.04 to 1.72). After the addition of coronary artery disease diagnosis as a time-varying covariate in the main model, the association was attenuated and no longer significant (adjusted hazard ratio, 1.27; 95 percent confidence interval, 0.99 to 1.62).
Avilash Mondal, M.D., from Nazareth Hospital in Philadelphia, and colleagues examined the association between CUD in elderly nonsmokers with established cardiovascular disease risk and MACCE. The researchers found that 13.9 percent of 28,535 elderly cannabis users reported MACCE episodes. Compared with the non-CUD cohort, the CUD cohort reported higher MACCE (odds ratio, 1.20), all-cause mortality, dysrhythmia, acute myocardial infarction, transfer to other facilities, and home health care. In CUD users, chronic lung disease, renal disease, hypertension, and hyperlipidemia were predictors of MACCE episodes.
"The main public message is to be more aware of the increased risks and open the lines of communication so that cannabis use is acknowledged and considered," Mondal said in a statement.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted November 2023
Read this next
Gains in Heart Failure Mortality Have Been Erased
FRIDAY, April 26, 2024 -- Declines in heart failure-related mortality from 1999 to 2012 were entirely reversed from 2012 to 2021, according to a research letter published online...
Seven in 10 Experiencing Homelessness Have a Mental Health Disorder
WEDNESDAY, April 17, 2024 -- The majority of people experiencing homelessness have mental health disorders, according to a review published online April 17 in JAMA...
Reports of Injuries, Deaths Prompt FDA to Recall Heart Failure Devices
WEDNESDAY, April 17, 2024 -- The HeartMate II and HeartMate 3, manufactured by Thoratec Corp., a subsidiary of Abbott Laboratories, are now under a strict U.S. Food and Drug...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.